Compare JAZZ & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | NVMI |
|---|---|---|
| Founded | 2003 | 1993 |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 15.1B |
| IPO Year | 2007 | 2001 |
| Metric | JAZZ | NVMI |
|---|---|---|
| Price | $248.75 | $429.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $217.57 | ★ $431.88 |
| AVG Volume (30 Days) | ★ 789.8K | 490.2K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.43 | N/A |
| Revenue | ★ $1,618,693,000.00 | N/A |
| Revenue This Year | $6.22 | $20.94 |
| Revenue Next Year | $7.68 | $19.53 |
| P/E Ratio | ★ $54.80 | $56.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $105.00 | $232.73 |
| 52 Week High | $250.49 | $615.99 |
| Indicator | JAZZ | NVMI |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 38.56 |
| Support Level | $222.49 | $415.57 |
| Resistance Level | $250.49 | $487.35 |
| Average True Range (ATR) | 7.32 | 27.28 |
| MACD | 0.01 | -5.09 |
| Stochastic Oscillator | 89.13 | 8.21 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.